Alerts will be sent to your verified email
Verify Email
BAJAJHCARE
|
Bajaj Healthcare
|
IOL Chem & Pharma
|
Hester Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.35 % | 0.91 % | 1.53 % |
|
Financials
|
|||
|
5 yr Average ROE
|
9.93 % | 9.87 % | 12.14 % |
|
5yr average Equity Multiplier
|
2.26 | 1.41 | 2.11 |
|
5yr Average Asset Turnover Ratio
|
0.95 | 1.03 | 0.45 |
|
5yr Avg Net Profit Margin
|
3.65 % | 6.75 % | 12.98 % |
|
Price to Book
|
3.67 | 1.1 | 4.46 |
|
P/E
|
0.0 | 18.73 | 51.0 |
|
5yr Avg Cash Conversion Cycle
|
15.4 Days | 45.42 Days | 83.43 Days |
|
Inventory Days
|
51.52 Days | 64.41 Days | 106.53 Days |
|
Days Receivable
|
72.17 Days | 83.56 Days | 94.77 Days |
|
Days Payable
|
83.01 Days | 94.27 Days | 142.53 Days |
|
5yr Average Interest Coverage Ratio
|
7.11 | 17.62 | 7.46 |
|
5yr Avg ROCE
|
24.2 % | 13.96 % | 12.53 % |
|
5yr Avg Operating Profit Margin
|
16.67 % | 10.94 % | 24.84 % |
|
5 yr average Debt to Equity
|
0.86 | 0.03 | 0.74 |
|
5yr CAGR Net Profit
|
n/a | -4.32 % | -8.32 % |
|
5yr Average Return on Assets
|
5.32 % | 6.97 % | 5.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.19 % | 52.62 % | 53.73 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-8.07 % | 8.93 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.64 % | 0.0 | -0.03 % |
|
Bajaj Healthcare
|
IOL Chem & Pharma
|
Hester Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|